Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/0301-4738.158070 http://scihub22266oqcxt.onion/10.4103/0301-4738.158070 C4463555!4463555!26044470     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Indian+J+Ophthalmol 2015 ; 63 (4): 318-22 Nephropedia Template TP {{tp|p=26044470|t=2015. Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy |pdf=|usr=}}{{26044470}} gab.com Text Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy JO: Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=26044470 #FOAvip Purpose:: To evaluate safety and efficacy of intravenous pulse cyclophosphamide (CyP) in acute macular serpiginous choroiditis (SC). Methods:: Patients with acute macular SC with lesions threatening and/or involving fovea were enrolled. All patients received CyP (1 g/m2 ) for 3 days followed by high-dose oral steroids (1.5 mg/kg) tapered over 6 months and monitored for visual acuity, response to treatment and systemic side effects. Results:: Eight patients (seven unilateral and one bilateral) with median age of 27 years (range: 13?40 years) were recruited. Mean visual acuity at presentation was 0.71 ± 0.35 logarithm of the minimum angle of resolution while postpulse visual acuity was 0.40 ± 0.32. Final mean visual acuity at 1-year was 0.31 ± 0.23 (P ? 0.05). Three eyes had recurrence and 3 patients developed transient hair loss with no other adverse effect. Conclusion:: Intravenous CyP provides rapid resolution of lesion activity and thereby helps in maintaining good functional acuity. Twit Text FOAVip Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy ????Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=26044470 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26044470 #FOAvip English Wikipedia <ref>{{Cite pmid|26044470}}</ref> Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy #MMPMID26044470 Venkatesh P; Gogia V; Gupta S; Tayade A; Shilpy N; Shah BM; Guleria R Indian J Ophthalmol 2015[Apr]; 63 (4): 318-22 PMID26044470show ga Purpose:: To evaluate safety and efficacy of intravenous pulse cyclophosphamide (CyP) in acute macular serpiginous choroiditis (SC). Methods:: Patients with acute macular SC with lesions threatening and/or involving fovea were enrolled. All patients received CyP (1 g/m2 ) for 3 days followed by high-dose oral steroids (1.5 mg/kg) tapered over 6 months and monitored for visual acuity, response to treatment and systemic side effects. Results:: Eight patients (seven unilateral and one bilateral) with median age of 27 years (range: 13?40 years) were recruited. Mean visual acuity at presentation was 0.71 ± 0.35 logarithm of the minimum angle of resolution while postpulse visual acuity was 0.40 ± 0.32. Final mean visual acuity at 1-year was 0.31 ± 0.23 (P ? 0.05). Three eyes had recurrence and 3 patients developed transient hair loss with no other adverse effect. Conclusion:: Intravenous CyP provides rapid resolution of lesion activity and thereby helps in maintaining good functional acuity. äPulse cyclophosphamide therapy in the management of patients with macu(epmc).pdf DeepDyve Pubget Overpricing